2025-03-052026-03-312026-03-31false16293433HJW THERAPY LTD2026-08-07falseiso4217:GBPxbrli:pure162934332025-03-04162934332026-03-31162934332025-03-052026-03-31162934332025-03-03162934332025-03-04162934332025-03-042025-03-0416293433bus:SmallEntities2025-03-052026-03-3116293433bus:AuditExempt-NoAccountantsReport2025-03-052026-03-3116293433bus:FullAccounts2025-03-052026-03-3116293433bus:PrivateLimitedCompanyLtd2025-03-052026-03-3116293433core:WithinOneYear2026-03-3116293433core:AfterOneYear2026-03-3116293433core:WithinOneYear2025-03-0416293433core:AfterOneYear2025-03-0416293433core:ShareCapital2026-03-3116293433core:SharePremium2026-03-3116293433core:RevaluationReserve2026-03-3116293433core:OtherReservesSubtotal2026-03-3116293433core:RetainedEarningsAccumulatedLosses2026-03-3116293433core:ShareCapital2025-03-0416293433core:SharePremium2025-03-0416293433core:RevaluationReserve2025-03-0416293433core:OtherReservesSubtotal2025-03-0416293433core:RetainedEarningsAccumulatedLosses2025-03-0416293433core:LandBuildings2026-03-3116293433core:PlantMachinery2026-03-3116293433core:Vehicles2026-03-3116293433core:FurnitureFittings2026-03-3116293433core:OfficeEquipment2026-03-3116293433core:NetGoodwill2026-03-3116293433core:IntangibleAssetsOtherThanGoodwill2026-03-3116293433core:ListedExchangeTraded2026-03-3116293433core:UnlistedNon-exchangeTraded2026-03-3116293433core:LandBuildings2025-03-0416293433core:PlantMachinery2025-03-0416293433core:Vehicles2025-03-0416293433core:FurnitureFittings2025-03-0416293433core:OfficeEquipment2025-03-0416293433core:NetGoodwill2025-03-0416293433core:IntangibleAssetsOtherThanGoodwill2025-03-0416293433core:ListedExchangeTraded2025-03-0416293433core:UnlistedNon-exchangeTraded2025-03-0416293433core:LandBuildings2025-03-052026-03-3116293433core:PlantMachinery2025-03-052026-03-3116293433core:Vehicles2025-03-052026-03-3116293433core:FurnitureFittings2025-03-052026-03-3116293433core:OfficeEquipment2025-03-052026-03-3116293433core:NetGoodwill2025-03-052026-03-3116293433core:IntangibleAssetsOtherThanGoodwill2025-03-052026-03-3116293433core:ListedExchangeTraded2025-03-052026-03-3116293433core:UnlistedNon-exchangeTraded2025-03-052026-03-3116293433core:MoreThanFiveYears2025-03-052026-03-3116293433core:Non-currentFinancialInstruments2026-03-3116293433core:Non-currentFinancialInstruments2025-03-0416293433dpl:CostSales2025-03-052026-03-3116293433dpl:DistributionCosts2025-03-052026-03-3116293433core:LandBuildings2025-03-052026-03-3116293433core:PlantMachinery2025-03-052026-03-3116293433core:Vehicles2025-03-052026-03-3116293433core:FurnitureFittings2025-03-052026-03-3116293433core:OfficeEquipment2025-03-052026-03-3116293433dpl:AdministrativeExpenses2025-03-052026-03-3116293433core:NetGoodwill2025-03-052026-03-3116293433core:IntangibleAssetsOtherThanGoodwill2025-03-052026-03-3116293433dpl:GroupUndertakings2025-03-052026-03-3116293433dpl:ParticipatingInterests2025-03-052026-03-3116293433dpl:GroupUndertakingscore:ListedExchangeTraded2025-03-052026-03-3116293433core:ListedExchangeTraded2025-03-052026-03-3116293433dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-03-052026-03-3116293433core:UnlistedNon-exchangeTraded2025-03-052026-03-3116293433dpl:CostSales2025-03-042025-03-0416293433dpl:DistributionCosts2025-03-042025-03-0416293433core:LandBuildings2025-03-042025-03-0416293433core:PlantMachinery2025-03-042025-03-0416293433core:Vehicles2025-03-042025-03-0416293433core:FurnitureFittings2025-03-042025-03-0416293433core:OfficeEquipment2025-03-042025-03-0416293433dpl:AdministrativeExpenses2025-03-042025-03-0416293433core:NetGoodwill2025-03-042025-03-0416293433core:IntangibleAssetsOtherThanGoodwill2025-03-042025-03-0416293433dpl:GroupUndertakings2025-03-042025-03-0416293433dpl:ParticipatingInterests2025-03-042025-03-0416293433dpl:GroupUndertakingscore:ListedExchangeTraded2025-03-042025-03-0416293433core:ListedExchangeTraded2025-03-042025-03-0416293433dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-03-042025-03-0416293433core:UnlistedNon-exchangeTraded2025-03-042025-03-0416293433core:NetGoodwill2026-03-3116293433core:IntangibleAssetsOtherThanGoodwill2026-03-3116293433core:LandBuildings2026-03-3116293433core:PlantMachinery2026-03-3116293433core:Vehicles2026-03-3116293433core:FurnitureFittings2026-03-3116293433core:OfficeEquipment2026-03-3116293433core:AfterOneYear2026-03-3116293433core:WithinOneYear2026-03-3116293433core:ListedExchangeTraded2026-03-3116293433core:UnlistedNon-exchangeTraded2026-03-3116293433core:ShareCapital2026-03-3116293433core:SharePremium2026-03-3116293433core:RevaluationReserve2026-03-3116293433core:OtherReservesSubtotal2026-03-3116293433core:RetainedEarningsAccumulatedLosses2026-03-3116293433core:NetGoodwill2025-03-0416293433core:IntangibleAssetsOtherThanGoodwill2025-03-0416293433core:LandBuildings2025-03-0416293433core:PlantMachinery2025-03-0416293433core:Vehicles2025-03-0416293433core:FurnitureFittings2025-03-0416293433core:OfficeEquipment2025-03-0416293433core:AfterOneYear2025-03-0416293433core:WithinOneYear2025-03-0416293433core:ListedExchangeTraded2025-03-0416293433core:UnlistedNon-exchangeTraded2025-03-0416293433core:ShareCapital2025-03-0416293433core:SharePremium2025-03-0416293433core:RevaluationReserve2025-03-0416293433core:OtherReservesSubtotal2025-03-0416293433core:RetainedEarningsAccumulatedLosses2025-03-0416293433core:NetGoodwill2025-03-0316293433core:IntangibleAssetsOtherThanGoodwill2025-03-0316293433core:LandBuildings2025-03-0316293433core:PlantMachinery2025-03-0316293433core:Vehicles2025-03-0316293433core:FurnitureFittings2025-03-0316293433core:OfficeEquipment2025-03-0316293433core:AfterOneYear2025-03-0316293433core:WithinOneYear2025-03-0316293433core:ListedExchangeTraded2025-03-0316293433core:UnlistedNon-exchangeTraded2025-03-0316293433core:ShareCapital2025-03-0316293433core:SharePremium2025-03-0316293433core:RevaluationReserve2025-03-0316293433core:OtherReservesSubtotal2025-03-0316293433core:RetainedEarningsAccumulatedLosses2025-03-0316293433core:AfterOneYear2025-03-052026-03-3116293433core:WithinOneYear2025-03-052026-03-3116293433core:Non-currentFinancialInstrumentscore:CostValuation2025-03-052026-03-3116293433core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-052026-03-3116293433core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-052026-03-3116293433core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-052026-03-3116293433core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-052026-03-3116293433core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-052026-03-3116293433core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-052026-03-3116293433core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-052026-03-3116293433core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-052026-03-3116293433core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3116293433core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3116293433core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3116293433core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3116293433core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3116293433core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3116293433core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3116293433core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3116293433core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3116293433core:Non-currentFinancialInstrumentscore:CostValuation2025-03-0416293433core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-0416293433core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-0416293433core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-0416293433core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-0416293433core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-0416293433core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-0416293433core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-0416293433core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-0416293433bus:Director12025-03-052026-03-31

HJW THERAPY LTD

Registered Number
16293433
(England and Wales)

Unaudited Financial Statements for the Period ended
31 March 2026

HJW THERAPY LTD
Company Information
for the period from 5 March 2025 to 31 March 2026

Director

WITHEROW, Hannah Jane

Registered Address

1 Gemini Court, 42a Throwley Way
Sutton
SM1 4AF

Registered Number

16293433 (England and Wales)
HJW THERAPY LTD
Statement of Financial Position
31 March 2026

Notes

2026

£

£

Fixed assets
Intangible assets323,672
23,672
Current assets
Debtors4725
Cash at bank and on hand10,865
11,590
Creditors amounts falling due within one year5(34,689)
Net current assets (liabilities)(23,099)
Total assets less current liabilities573
Net assets573
Capital and reserves
Called up share capital100
Profit and loss account473
Shareholders' funds573
The financial statements were approved and authorised for issue by the Director on 7 August 2026, and are signed on its behalf by:
WITHEROW, Hannah Jane
Director
Registered Company No. 16293433
HJW THERAPY LTD
Notes to the Financial Statements
for the period ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
2.Average number of employees

2026
Average number of employees during the year1
3.Intangible assets

Other

Total

££
Cost or valuation
Additions29,59029,590
At 31 March 2629,59029,590
Amortisation and impairment
Charge for year5,9185,918
At 31 March 265,9185,918
Net book value
At 31 March 2623,67223,672
At 04 March 25--
4.Debtors: amounts due within one year

2026

£
Trade debtors / trade receivables250
Prepayments and accrued income475
Total725
5.Creditors: amounts due within one year

2026

£
Taxation and social security2,734
Other creditors30,045
Accrued liabilities and deferred income1,910
Total34,689